Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: This study aimed to identify parameters that allow the estimation of tumor-infiltrated lymph nodes (LN) after pretreatment for unilateral Wilms tumor (WT).
Summary Background Data: Complete tumor resection with removal of regional LN is always necessary. Positive LNs require local irradiation influencing benefits in case of NSS in long-term follow-up. Clinical and tumor-related data available at the time of surgery in combination with intraoperative findings (IAF) were used to estimate the LN status during surgery.
Methods: Altogether, 2115 patients with unilateral WT were prospectively enrolled in SIOP-93-01 / GPOH and SIOP-2001 / GPOH over a period of 30 years (1993-2023). LN infiltration by tumor was calculated for age, sex, metastases at diagnosis, tumor volume (TV), TV shrinkage, and intraoperative findings (IAF) using logistic regression models.
Results: Age ≥48 months (P<0.001, OR 2.17, CI 1.57 - 3.00), TV at diagnosis ≥300 (P<0.001, OR 3.72, CI 2.37 - 5.85), metastasis at diagnosis (P<0.001, OR 6.21, CI 4.47 - 8.62) and IAF (>1: P<0.001, OR 3.54, CI 2.13 - 5.88) correlated with positive LNs. TV shrinkage was not predictive of positive LN. Three flow charts were developed based on age, TV at diagnosis, metastasis, and IAF. These flowcharts defined risks between 0% and 41.5% for LN infiltration by tumor.
Conclusions: The combination of age, TV at diagnosis, and metastasis with IAF allows the estimation of the frequency of positive LNs, which may help surgeons deciding about NSS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SLA.0000000000006393 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
J Natl Compr Canc Netw
August 2025
31National Comprehensive Cancer Network.
The NCCN Clinical Practice Guidelines (NCCN Guidelines) for Wilms Tumor (WT; nephroblastoma) cover strategies for the screening, diagnosis, and treatment of WT, which is the most frequent primary kidney tumor in children. WT can generally be separated into 2 histology types: favorable histology WT and anaplastic WT. Five-year survival is high for children with favorable histology WT who receive appropriate treatment; however, survival rates are much lower for patients who present with higher stage diffuse anaplastic WT.
View Article and Find Full Text PDFPatterns of Care and Survival of Wilms Tumor in Children in India: A Retrospective Multicentric INPHOG Study.
Pediatr Blood Cancer
September 2025
Pediatric Oncology Disease Management Group, Max Super Specialty Hospital, New Delhi, India.
Unlabelled: Renal cancers are rare in children, accounting 6-7% of childhood tumors. In India, there is paucity of data on renal tumors including Wilms tumor (WT).
Aims: To describe the patterns of care of children with WT; 1, 3, and 5 year event-free survival (EFS) and overall survival (OS).
Background: Wilms tumour (WT), the most common paediatric kidney tumour, is treated in Morocco following the SIOP protocol, which practices neoadjuvant chemotherapy (NAC). The response to NAC can be assessed by considering both tumor volume reduction and the proportion of therapy-induced changes observed in histological specimens, including necrosis. This retrospective study assesses the impact of NAC on tumour volume across various WT histotypes and correlates these changes with proportions of therapy-induced necrosis.
View Article and Find Full Text PDFDistinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor.
Genome Med
May 2025
Developmental Biochemistry, Theodor-Boveri-Institute/Biocenter, Julius-Maximilians-University Würzburg, Am Hubland, Würzburg, 97074, Germany.
Background: Genetic predisposition is particularly common in children with the kidney cancer, Wilms tumor. In 10% of these children, this manifests as a family history of Wilms tumor or bilateral disease. The frequency and spectrum of underlying changes have not been systematically investigated.
View Article and Find Full Text PDFSecond Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey.
J Pediatr Hematol Oncol
July 2025
Departments of Pediatric Oncology.
Background: It has been reported that the risk of second malignant neoplasms (SMNs) in long-term follow-up patients with heritable retinoblastoma (Rb) is significantly increased compared with patients with non-heritable Rb and the general population. In this study, we investigated the types, frequencies, clinical and pathologic features, potential risk factors, and outcomes of SMNs occurring in a large group of retinoblastoma patients that were diagnosed, treated, and followed up for a long time in our Pediatric Oncology unit.
Methods: Our study comprehensively analyzed records of Rb patients followed up at Hacettepe University Pediatric Oncology Department over a 51-year period from January 1972 to January 2023.